RenovoRx | IPO Presentation Deck | 29 slides

RenovoRx · 2021-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
04
The slide serves as a high-level company summary, highlighting clinical status, mechanism of action, market size, and regulatory moat.summarize
Open slide detailLoop · Golden Circle
05
The slide uses a circular graphic for the total market and two white boxes for supporting market assumptions.size_opportunity
Open slide detailBeat · Market SizeLoop · Golden Circle
06
frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
07
Uses a visual comparison of vascular structures to illustrate the clinical problem.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
08
Includes a visual process flow (before/after) and a line chart illustrating the pressure dynamics over time.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
09
The slide outlines the clinical workflow for a medical procedure.present_framework
Open slide detailBeat · SolutionLoop · Golden Circle
10
This is a visual representation of a medical device mechanism of action, likely for a biotech or medtech pitch.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
11
The slide outlines the clinical process flow for a medical procedure.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
12
present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
13
The slide uses a simple additive visual representation to explain the drug-device combination.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
14
The slide uses a horizontal bar chart format to represent clinical trial progress across different indications.plan_implementation
Open slide detailLoop · Golden Circle
15
The chart uses a broken axis for the Lung (NSCLC) category to accommodate the higher incidence rate.size_opportunity
Open slide detailLoop · Golden Circle
16
other
Open slide detailLoop · Golden Circle
17
transition
Open slide detailLoop · Golden Circle
18
The slide highlights historical control benchmarks to set the stage for clinical trial efficacy.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
19
The chart shows a Kaplan-Meier style survival curve comparing Gem Alone vs Gem + Radiation.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
20
Includes Kaplan-Meier survival curve comparing RenovoRx treatment to historical controls (Gem Alone and Gem + Radiation).show_traction
Open slide detailBeat · TractionLoop · Golden Circle
21
The slide outlines a clear regulatory and clinical strategy for a medical device/drug trial.argue_timing
Open slide detailLoop · Golden Circle
22
The slide outlines a clinical trial design comparing standard IV Gemcitabine + Abraxane against RenovoGem intra-arterial treatment.plan_implementation
Open slide detailLoop · Golden Circle
23
The slide highlights clinical trial progress with a specific count of sites and patient enrollment percentage.show_traction
Open slide detailLoop · Golden Circle
24
Includes clinical trial design details (interim analysis, DMC authority) and a table of patient enrollment metrics.analyze_data
Open slide detailLoop · Golden Circle
25
The slide outlines a clinical trial protocol including induction, randomization, and primary endpoint.plan_implementation
Open slide detailLoop · Golden Circle
26
other
Open slide detailBeat · TeamLoop · Golden Circle
27
other
Open slide detailBeat · TeamLoop · Golden Circle
28
summarize
Open slide detailLoop · Golden Circle
29
state_next_steps